Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Carbohydrate Loading: Effective If Done Right for Even a Day
by Sheri Colberg, PhD
Letter from the Editor
It used to be that many of our diabetes patients would slow their activities as the weather got colder and the days got shorter. However, the development of indoor devices such as Peloton style cycles and rowers, and indoor running and cycling trainers that mimic outdoor activities, means hard exercise and competitions can occur during the worst weather. These new types of activities mean that worrying about proper nutrition or race loading of fuel doesn’t stop when the snow hits the ground.
This week our exercise expert, Dr. Sheri Colberg, shares her insight on how carb loading, activity and diabetes can work together without danger.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
By Sheri Colberg, PhD
What is a better topic to discuss after the gluttony most of us experience over the Thanksgiving and other fall/winter holidays than carbohydrate loading? (Actually, it probably should be excess calorie consumption in general, but you get the idea.) The following is excerpted from The Athlete’s Guide to Diabetes (2019) and gives you a better understanding of the topic from an exercise physiology (and diabetes) point of view.
Resistant hypertension and type 2 diabetes lead to both microvascular and macrovascular complications.
Breast milk is deemed to be the “best” for baby, but what are the additional benefits for mothers and their long-term health?
Fact: Why Every Patient Needs to Get An A1c Test
A recent study in the December 2019 Issue of Diabetes Care Journal explains why patients who do not have obesity should be tested for diabetes and prediabetes. Overweight and obesity are well-established risk factors for diabetes; however, evidence suggests that the relationship between body weight and diabetes risk may differ by race/ethnicity, which has implications for the prevention, screening, and treatment of individuals who develop diabetes with a BMI below the overweight or obesity range. In this study, racial/ethnic disparities in the prevalence of diabetes by BMI category in a large, racially/ethnically and geographically diverse cohort of 4.9 million adults were examined. Individuals enrolled in the cohort were from six racial/ethnic groups, including white, black, Hispanic, Asian, Hawaiian/Pacific Islander, and American Indian/Alaskan Native. Compared with whites, all other racial/ethnic groups had a higher prevalence of diabetes at any given BMI, and these differences were more pronounced in lower BMI categories. Strikingly, in those with a normal weight, the prevalence of diabetes was 5.0% in whites, 10.1% in Asians and American Indians/Alaskan Natives, 13.0% in Hispanics, 13.5% in Blacks, and 18.0% in Hawaiians/Pacific Islanders.
Obesity-driven insulin resistance may not be sufficient to explain the high prevalence of diabetes in nonobese people, and other factors, such as poor insulin secretion, may be at play in the early natural history. It is, therefore, important to acknowledge the elevated risk of diabetes at low BMI in many large populations. Diagnosing prediabetes earlier can save billions and improve the quality of life for your patients. Therefore, not only should screening practices be tailored to identify high-risk individuals in the absence of obesity better, but additional research focusing on more effective interventions in this population is warranted, as are mechanistic studies to identify pathophysiological pathways contributing to the natural history of diabetes incidence in normal-weight individuals.
Diabetes Care 2019 Dec; 42(12): 2164-2166. https://doi.org/10.2337/dci19-0046
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Jordan Boyd, PharmD. Candidate Florida Agricultural & Mechanical University School of Pharmacy
Andrew Daoud, PharmD Candidate, Florida A&M University
Usif Darwish, PharmD Candidate, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences
Onyi Ibeji, PharmD. Candidate, LECOM School of Pharmacy
Amber Satz, PharmD Candidate, LECOM School of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.